Orient Pharma Co., Ltd. (TPEX:4166)

Taiwan · Delayed Price · Currency is TWD

25.30

-0.50 (-1.94%)

Apr 20, 2026, 12:56 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Overseas Business Division			39.02M	63.07M	45.91M	10.45M	8.62M
Overseas Business Division Growth			-38.14%	37.37%	339.39%	21.20%	8.22%
Plant Operating Department			847.11M	446.27M	416.30M	400.42M	343.92M
Plant Operating Department Growth			89.82%	7.20%	3.97%	16.43%	32.86%
Pharmaceutical Operations			3.78M	2.52M	1.13M	1.14M	995.00K
Pharmaceutical Operations Growth			50.24%	122.83%	-0.88%	14.57%	-63.31%
Total			889.91M	511.86M	463.34M	412.01M	353.54M
Total Growth			73.86%	10.47%	12.46%	16.54%	31.16%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			679.80M	253.78M	323.43M	412.01M	353.54M
Taiwan Growth			167.88%	-21.54%	-21.50%	16.54%	31.16%
United States			178.49M	216.26M	108.62M	-	-
United States Growth			-17.46%	99.09%	-	-	-
Philippines			23.81M	-	-	-	-
China			18.00K	37.92M	17.14M	-	-
China Growth			-99.95%	121.16%	-	-	-
Others			7.80M	3.91M	14.15M	-	-
Others Growth			99.23%	-72.34%	-	-	-
Total			889.91M	511.86M	463.34M	412.01M	353.54M
Total Growth			73.86%	10.47%	12.46%	16.54%	31.16%

Source: S&P Global Market Intelligence.